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INTRODUCTION
In the USA, drug misadventuring is derived 
from the actions or inactions of a variety of social, 
economic, political, and scientific-technological ‘en-
vironments’ (1). Prescribers, patients, pharmacists, 
manufacturers and policy-makers directly influence 
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This public policy problem necessitates the construc-
tion of new policy decisions in the best interest of the 
patient. In 1987, about 12000 deaths and 15000 hos-
pitalizations due to adverse drug reactions have been 
reported to the Food and Drug Administration in 
the USA (1,2). Drug-related morbidity and mortali-
ty are often preventable, and pharmaceutical servic-
es can reduce the number of adverse drug reactions, 
length of hospital stays, and cost of care. 
Pharmacists must abandon factionalism and 
adopt patient-centered pharmaceutical care as their 
philosophy of practice (3). Changing the focus of 
practice from products and biological systems to en-
suring the best drug therapy and patient safety raise 
pharmacy’s level of responsibility and require phil-
osophical, organizational, and functional changes. 
It is necessary to set new practice standards, estab-
26 
Scripta Scientifica Pharmaceutica, vol. 2, No. 2, 2015, pp. 25-30 
Copyright © Medical University of Varna
The challenging paradigm of pharmaceutical care
lish cooperative relationships with other health-care 
professions, and determine strategies for marketing 
pharmaceutical care. Pharmacy’s reprofessionaliza-
tion will be completed only when all pharmacists ac-
cept their social mandate to ensure the safe and ef-
fective drug therapy of the individual patient. 
ORIGIN OF PHARMACEUTICAL CARE 
PARADIGM
Pharmacy’s societal function should involve 
‘pharmaceutical care’, a concept that includes both 
drug-product control and clinical pharmacy services 
(4). There must be an appropriate philosophy of prac-
tice and an organizational structure within which to 
practice. In 1990, pharmaceutic care has been sug-
gested as paradigm of health for all in the year 2000 
(5). 
C. D. Hepler and L. M. Strand (1990) compre-
hensively explore pharmacy’s opportunity to mature 
as a profession by accepting its social responsibility to 
reduce preventable drug-related morbidity and mor-
tality.  Pharmacy has shed the apothecary role but 
has not yet been restored to its erstwhile importance 
in medical care. It is neither enough to dispense the 
correct drug or to provide sophisticated pharmaceu-
tical services, nor to devise new technical functions. 
Pharmacists and their institutions must stop look-
ing inward and start redirecting their energies to the 
greater social good. 
Practitioners of pharmaceutical care are con-
cerned with the effect of their services on patients’ 
quality of life and not merely with the act of provid-
ing services (6). They work with other health-care 
professionals as equals to ensure that therapeutic 
goals are achieved and that drug-related illness does 
not occur or is quickly detected and resolved. To be 
accepted and implemented, pharmaceutical care 
must first overcome pharmacy’s product- and ser-
vice-oriented focus, opposition from other health-
care professions and drug manufacturers, financial 
and logistical problems, and ignorance and inertia 
among pharmacists themselves. Through a united 
effort, pharmacy organizations, schools and individ-
ual pharmacists can translate the need for pharma-
ceutical care into demands for it by patients, insur-
ance companies, health maintenance organizations 
and the government as well. 
Drugs are administered for the purpose of 
achieving definite outcomes that improve patient’s 
quality of life (3,7). These outcomes are the follow-
ing: 1) cure of a disease; 2) reduction or elimination 
of symptoms; 3) arresting or slowing of a disease pro-
cess, and 4) preventing a disease or symptoms. Phar-
maceutical care is the responsible provision of such a 
drug therapy and involves three major functions on 
behalf of the patients: 1) identifying potential and ac-
tual drug-related problems; 2) resolving actual drug-
related problems, and 3) preventing potential drug-
related problems. Through the process of pharma-
ceutical care a pharmacist cooperates with a patient 
and other professionals in designing, implementing 
and monitoring a therapeutic plan that will produce 
specific therapeutic outcomes for the patient.
It represents a necessary element of health care 
and should be integrated with other elements. The 
pharmacist is responsible directly to the patient for 
the quality of this care. The fundamental relation-
ship in pharmaceutical care is a mutually beneficial 
exchange in which the patient grants authority to the 
provider and the provider promises competence and 
commitment (accepts responsibility) to the patient.
C. D. Hepler and L. M. Strand (1990) term the 
necessary philosophy of practice ‘pharmaceutical 
care’ and the organizational structure that facilitates 
the provision of this care the ‘pharmaceutical care-
system’. The mission of the pharmaceutical practice 
is to provide pharmaceutical care (4).
Meanwhile, growing numbers of practitioners 
worldwide have adopted pharmaceutical care as an 
integral component of pharmacy practice. Estab-
lished models of pharmaceutical care can reduce the 
burden of preventable drug therapy problems. Al-
though many challenges remain, the profession has 
key resources to expand and improve the delivery of 
pharmaceutical care (8).
PHARMACISTS’ ATTITUDES TOWARDS 
PHARMACEUTICAL CARE
The pharmacists begin to accept the mandate of 
pharmaceutical care when there is widespread train-
ing and use of technicians, implementation of prob-
lem-based education in the schools, and adequate 
problem-solving support for pharmacists in practice 
(9).
Scripta Scientifica Pharmaceutica, vol. 2, No. 2, 2015, pp. 25-30
Copyright © Medical University of Varna 27
Ivo Kumanov
The results from a cross-sectional survey 
among 86 Eritrean pharmacists indicate that 95% of 
them perceive that their current role needs to be re-
defined and re-oriented (10). Some 86% of them be-
lieve there is a great mismatch between pharmacists’ 
levels of education and practice in the work area. Al-
though they are proud to be pharmacy professionals, 
they want to redefine and reorient their current role 
into pharmaceutical care.
Within a descriptive, cross-sectional study of 
250 pharmacists working in the governmental hos-
pitals in Kuwait, overall positive attitudes towards 
pharmaceutical care are expressed (11). They feel 
well-prepared to implement the various aspects of 
pharmaceutical care, with the least preparedness in 
the administrative/management aspects. The phar-
macists with more practice experience present with 
significantly more positive attitudes towards phar-
maceutical care (p=0.001) and feet better prepared to 
provide pharmaceutical care competencies (p<0.001) 
than those with less practical experience. The re-
spondents agree/strongly agree that the most signif-
icant barriers to the integration of pharmaceutical 
care into practice are lack of private counseling areas 
or inappropriate pharmacy layout (87.6%), organiza-
tional obstacles (81.6%), inadequate staff (79.6%) as 
well as lack of pharmacist’s time and adequate tech-
nology (76.0% of the cases). Collaborative efforts be-
tween health authorities and educational institu-
tions, and the integration of innovative approaches 
in pharmacy management and education could over-
come these barriers and achieve the transition to-
wards pharmaceutical care practice.
When ambulatory care pharmacists engage in 
pharmaceutical patient care to their full capacity, 
physician time is saved, access to care is improved as 
well as clinical and economic outcomes are enhanced 
(12). There is a need for ambulatory care pharmacists 
to work toward optimizing the safe medication use 
and drug therapy for patients with diabetes mellitus, 
bronchial asthma, cardiovascular and renal diseases. 
There exist other opportunities for the development 
of ambulatory care pharmacy services in preven-
tive care, precision therapeutics, medication thera-
py management, mitigation of healthcare disparities, 
and implementation of national healthcare reform. 
Interprofessional patient care teams include  ambu-
latory care pharmacists in patient-centered medical 
homes and accountable care organizations. The am-
bulatory care pharmacy practice benefits by enhanc-
ing the specialty residency training and by creating 
the residency/fellowship for advanced subspecial-
ty clinical practice and research. By assertively such 
advancing practice, pharmacy can help achieve the 
national priorities of improving patient care, patient 
health, and affordability of care. Provider status is es-
sential to recognize pharmacists as an integral part 
of the patient care team.
A cross-sectional study among 80 managing 
pharmacists in 125 randomly selected community 
pharmacies in Flanders, Belgium, is performed (13). 
Usage is made of structured interviews concerning 
the current implementation level of PHARMACOP-
protocol that focuses on patient counselling within 
pharmaceutical care during prescription filling for 
chronic obstructive pulmonary disease. For first and 
follow-up prescriptions, 49% and 43% of pharma-
cists, respectively, need to spend at least five min ex-
tra to offer optimal patient counselling. Most barri-
ers for protocol implementation include lack of time 
(in 80%), no integration in pharmacy software (in 
61%), and too much administrative burden (in 58% 
of the responses).
The analysis of 51 surveys completed by com-
munity pharmacists in New York, the USA, dem-
onstrates that 90% of the respondents are confident 
in providing counselling about medications used to 
manage chronic kidney disease, 63% indicate confi-
dence in recommending drug dosing changes based 
on kidney function, 88% indicate a willingness to 
play a greater role in reviewing medications for such 
patients, and all agree that they will benefit from ed-
ucation about the complications of this disease and 
their management (14). The enhancement of the 
collaborative pharmaceutical care for patients with 
chronic kidney disease is emphasized.
Based on a pilot study about pharmaceutical 
care implantation in a general paediatric unit in a 
French hospital it is concluded that French pharma-
cists can apply the pharmaceutical care model fol-
lowing a specific training in a patient unit of a French 
pediatric hospital (15).
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PATIENTS’ ATTITUDES TOWARDS PHAR-
MACEUTICAL CARE
Within a randomized controlled trial among 
380 patients from a public emergency department at 
Restinga district in Porto Alegre, Southern Brazil, it 
has been established that pharmaceutical care inter-
ventions are feasible and effective in increasing the 
medication adherence in both hospital outpatient 
and community pharmacy settings (16). 
The intervention consisting of clinical pharma-
cist medication reconciliation, patient education and 
improved communication of the discharge medica-
tion plan as devised by the hospital physician and 
care team to primary care physicians and commu-
nity pharmacists and covering 592 patients from in-
ternal medicine, family medicine, cardiology and or-
thopedic services may affect the quality of the out-
patient medical record of these patients expressed by 
smaller mean number of medication discrepancies 
per patient for the enhanced group than that for the 
control group (17).
Usage of patient’s self-completion concordance 
forms by 99 patients in 24 Dutch and by 241 patients 
in 41 Bulgarian pharmacies is evaluated (18). A high-
er proportion of Bulgarian patients answer questions 
on these forms compared to Dutch ones. The pa-
tients from both countries are satisfied with the self-
completion concordance forms, consultation and 
newly-started medicine. These forms can be used in 
community pharmacies at the start of chronic treat-
ment and in order to develop indicators to measure 
patient’s involvement in pharmaceutical care.
The results from a pragmatic randomised con-
trolled trial of 144 women with epilepsy aged over 
18 years demonstrate that the application of a phar-
maceutical care programme significantly improves 
their health-related quality of life (19).
During a prospective study of renal transplant 
recipients, 35 patients receive the standardized drug 
and transplant training while 32 ones receive inten-
sified additional inpatient and outpatient pharma-
ceutical care and counselling by a dedicated clinical 
pharmacist (20). There is a significant improvement 
of patients’ immunosuppressive medication adher-
ence during the first post-transplant year that sug-
gests that this pharmaceutical care has the potential 
to improve outcomes after organ transplantation.
Within a randomized controlled study in Chi-
na, the individualized pharmaceutical care exerts a 
statistically significant favorable effect on medica-
tion adherence at six-month (p=0.016) and at one-
year follow-up (p=0.039) as well as on hospital ad-
mission (p=0.01) in chronic obstructive pulmonary 
disease patients (21).
In a randomized controlled trial of 945 partic-
ipants are assigned to minimal, enhanced and usu-
al pharmaceutical care groups (22). The minimal 
group receives admission history, medication recon-
ciliation, patient education, discharge medication list 
and medication recommendations to inpatient team 
and the enhanced one receives a faxed medication 
care plan to the community physician and pharma-
cy and telephone call three-five days post-discharge, 
too. The average medication appropriateness index 
per medication is 0.53 at discharge from hospital and 
increases up to 0.75 at 90 days, and this is true across 
all study groups. 
STUDENT’S EDICATION IN PHARMACEU-
TICAL CARE
The performance and perceptions of compe-
tency of 33 students in a new pharmaceutical care 
course conducted in the first semester of 2014, in the 
Federal University of Sergipe, Brazil, that uses ac-
tive learning methodologies are evaluated (23). The 
overall mean of students’ scores on a scale of 0 to 10 
points is 7.97±0.59, as student’s performance on the 
virtual patient method is statistically superior to oth-
er methods. With respect to the perception of com-
petency in pharmaceutical care practice, a compar-
ison of pre- and post-test scores reveals statistical-
ly significant improvement for all evaluated compe-
tences. Finally, the students present positive opinions 
of this pharmaceutical care course.
The results from a descriptive, cross-section-
al survey of 126 pharmacy students in the Facul-
ty of Pharmacy, Kuwait University, Kuwait, indicate 
their overall positive attitudes towards pharmaceu-
tical care (24). They feel prepared to implement the 
various aspects of pharmaceutical care, with the least 
preparedness in the administrative/management as-
pects and appreciate the importance of the various 
pharmaceutical care competencies. The pharma-
cy students agree/strongly agree that the major bar-
riers to the integration of pharmaceutical care into 
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practice are lack of private counseling areas or inap-
propriate pharmacy layout (95.2%), lack of pharma-
cists’ time (83.3%), organizational obstacles (82.6%), 
and pharmacists’ physical separation from patient 
care areas (82.6% of the respondents). Their attitudes 
and perceived preparedness can serve as needs as-
sessment tools to guide curricular change and im-
provement. This policy enables their development as 
change agents who can advance pharmacist-provid-
ed direct patient care.
The results from a questionnaire study of 143 
final-year students in pharmacy preparing to be-
come community pharmacists, at the University Par-
is-Descartes in Paris, France, indicate their attitudes 
towards the future provision of pharmaceutical care 
(25). The most significant barriers perceived by the 
students are the following: working time, remuner-
ation and organizational problems, specifically the 
need to create a physical location for consultations to 
respect patients’ privacy within a pharmacy.
In the course of the project ‘Redefinition and 
approbation of the academic curricula and syllabi 
of the Faculty of Pharmacy at the Medical Univer-
sity ‘Prof. Dr. Paraskev Stoyanov’ of Varna in com-
pliance with the needs and requirements of the la-
bor market’ within the framework of the European 
Social Fund, Human Resources Development Oper-
ational Programme of the European Commission, 
Bulgarian pharmacists’ attitudes in this respect were 
comprehensively evaluated (26). The assessment of a 
representative sample of 100 respondents indicated a 
relatively highly perceived significance of the educa-
tion in pharmaceutical care along with a less suffi-
cient practical training in this discipline in Bulgaria.
CONCLUSION
In recent years, convincing evidence accumu-
lates of the feasibility and effectiveness of a variety of 
interventions immediately associated with pharma-
ceutical care aiming at improving patients’ relation-
ships with master pharmacists in public pharmacies. 
Hospital pharmacists recommend a broader practi-
cal implementation of pharmaceutical care. The in-
teractive pharmacy students’ learning can enhance 
their pharmaceutical care competences. The collab-
oration between health authorities and educational 
institutions along with the integration of innovative 
approaches in the management of community and 
hospital pharmacies and pharmacy education is nec-
essary to overcome the organizational, technical and 
professional barriers in this respect. 
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